David S Klimstra Selected Research

Serous Cystadenoma

10/2012	Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
5/2012	Microcystic serous cystadenoma of the pancreas with subtotal cystic degeneration: another neoplastic mimic of pancreatic pseudocyst.
2/2012	Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms.
12/2011	Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
2/2006	Lipid-rich variant of pancreatic endocrine neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Klimstra Research Topics

Disease

148	Neoplasms (Cancer) 01/2023 - 01/2002
34	Carcinoma (Carcinomatosis) 01/2022 - 01/2002
29	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 04/2002
28	Adenocarcinoma 01/2023 - 01/2002
27	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2003
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2004
13	Microsatellite Instability 01/2021 - 11/2003
13	Neoplasms, Cystic, Mucinous, and Serous 12/2015 - 01/2002
11	Carcinogenesis 01/2022 - 03/2007
10	Acinar Cell Carcinoma 10/2017 - 03/2002
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2022 - 10/2014
6	Cholangiocarcinoma 01/2020 - 11/2013
5	Fibrosis (Cirrhosis) 01/2019 - 08/2002
5	Disease Progression 01/2018 - 07/2008
5	Cysts 01/2014 - 05/2002
5	Serous Cystadenoma 10/2012 - 02/2006
4	Margins of Excision 12/2022 - 02/2008
4	Adenoma (Adenomas) 01/2022 - 02/2004
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 11/2009
4	Hepatocellular Carcinoma (Hepatoma) 04/2019 - 08/2002
4	Necrosis 12/2012 - 02/2004
4	Residual Neoplasm 03/2011 - 07/2002
4	Rectal Neoplasms (Rectal Cancer) 01/2011 - 07/2002
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 03/2010 - 10/2002
3	Retinoblastoma (Glioblastoma, Retinal) 01/2018 - 05/2005
3	Colonic Neoplasms (Colon Cancer) 03/2014 - 04/2006
3	Stomach Neoplasms (Stomach Cancer) 03/2012 - 12/2007
3	Carcinoid Tumor (Carcinoid) 08/2010 - 10/2008
2	Choledochal Cyst (Choledochal Cysts) 01/2022 - 10/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 09/2007
2	Melanoma (Melanoma, Malignant) 01/2022 - 03/2005
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 05/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 09/2006
2	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2019 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 07/2003
2	Intellectual Disability (Idiocy) 01/2018 - 03/2011
2	Turcot syndrome 01/2018 - 10/2016
2	Thalassemia 01/2018 - 03/2011
2	Inflammation (Inflammations) 12/2015 - 05/2010
2	Pancreatoblastoma 03/2015 - 10/2011
2	Genomic Instability 11/2014 - 12/2008

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
23	MucinsIBA 10/2018 - 01/2002
19	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2007
17	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2002
7	EnzymesIBA 01/2022 - 10/2008
7	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2010
6	AlbuminsIBA 01/2020 - 08/2002
6	ParaffinIBA 01/2020 - 06/2011
6	Keratins (Keratin)IBA 01/2020 - 05/2002
6	Colloids (Colloid)IBA 12/2019 - 01/2002
6	CateninsIBA 01/2019 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2020 - 08/2002
5	AntibodiesIBA 03/2017 - 10/2002
5	Tumor Viral Antigens (Large T Antigen)IBA 09/2009 - 12/2003
5	beta CateninIBA 10/2008 - 03/2002
4	PlatinumIBA 01/2021 - 01/2002
4	Immune Checkpoint InhibitorsIBA 10/2019 - 11/2016
4	Phosphotransferases (Kinase)IBA 12/2017 - 09/2006
4	Glycoproteins (Glycoprotein)IBA 03/2017 - 10/2002
4	Pancreatic Elastase (Elastase)IBA 12/2016 - 12/2003
4	B72.3 antibodyIBA 10/2014 - 09/2010
4	SynaptophysinIBA 08/2013 - 05/2008
4	ChromograninsIBA 11/2012 - 07/2002
4	Cyclin D1IBA 09/2012 - 04/2002
3	ProteomeIBA 02/2024 - 01/2020
3	Calcibiotic Root Canal SealerIBA 01/2021 - 12/2014
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2004
3	Formaldehyde (Formol)FDA Link 01/2020 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
3	MesothelinIBA 11/2016 - 06/2005
3	TrypsinIBA 08/2013 - 10/2008
3	Chymotrypsin FDA Link 08/2013 - 10/2008
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2011 - 08/2002
3	Immunoglobulin G (IgG)IBA 11/2011 - 11/2004
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2010 - 08/2002
3	ErbB Receptors (EGF Receptor)IBA 04/2006 - 03/2005
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 06/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 01/2018
2	GadoliniumIBA 01/2019 - 08/2014
2	Chromogranin AIBA 01/2019 - 08/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017 - 03/2007
2	MethyltransferasesIBA 01/2017 - 03/2008
2	O-(6)-methylguanineIBA 01/2017 - 03/2008
2	Differentiation AntigensIBA 11/2016 - 12/2003
2	amsonic acid (DAS)IBA 11/2016 - 03/2010
2	GlypicansIBA 08/2016 - 09/2010
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2014 - 09/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 07/2013 - 03/2005
2	Hematoxylin (Haematoxylon)IBA 07/2013 - 03/2005

Therapy/Procedure

34	Therapeutics 02/2024 - 07/2002
22	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
11	Neoadjuvant Therapy 01/2023 - 07/2002
4	Radiotherapy 01/2019 - 07/2002
4	Hepatectomy 09/2012 - 12/2003
3	Immunotherapy 01/2022 - 01/2019
3	Colectomy 03/2015 - 10/2008
3	Cholecystectomy 12/2011 - 04/2009
2	Pancreatectomy 01/2022 - 11/2004
2	Radiofrequency Ablation 03/2014 - 12/2012